180 Life Sciences Holds $349M in ETH, $238M in Cash Equivalents

180 Life Sciences announced it holds 82,186 Ether at an average acquisition price of $3,806.71, valued at approximately $349 million. In addition to ETH, the company has around $238 million in USD cash equivalents.

180 Life Sciences Corp. (ATNF), now operating as ETHZilla, has announced a significant acquisition of 82,186 Ether (ETH) tokens, valued at approximately $349 million as of August 11, 2025. The company acquired the cryptocurrency at an average price of $3,806.71 per token [1]. Alongside its ETH holdings, ETHZilla maintains approximately $238 million in USD cash equivalents, bringing its total treasury to nearly $587 million [2].

The acquisition was part of a PIPE (Private Investment in Public Equity) transaction completed last week, which provided capital for the cryptocurrency purchases. McAndrew Rudisill, Executive Chairman of the company, stated, "At ETHZilla, we have put over $350 million in capital to work since the PIPE transaction we completed last week, and have executed on our strategy to rapidly build a differentiated Ethereum treasury vehicle" [1].

The firm plans to rebrand as ETHZilla Corporation and has partnered with Electric Capital to manage its treasury strategy. The recently purchased ETH will be staked through Electric Capital’s Ethereum network strategies to generate yield, according to the company [1]. ETHZilla has 154.032 million shares outstanding as of August 5, 2025 [2].

The company intends to continue operating its existing biotech assets while developing its gaming initiatives. Updates on treasury management and yield generation strategies will be provided through public releases and regulatory filings [1].

References:
[1] https://www.investing.com/news/cryptocurrency-news/180-life-sciences-reports-349-million-eth-holdings-after-strategy-shift-432SI-4184949
[2] https://za.investing.com/news/stock-market-news/180-life-sciences-stock-soars-after-revealing-massive-eth-holdings-93CH-3833671